title: [Treatment of small cell lung cancer: limited disease. Guidelines of clinical practice made by the European Lung Cancer Working Party].
abstract: These updated clinical practice guidelines on the treatment of small cell lung cancer (SCLC) limited disease formulated by the ELCWP aim to answer the following questions: 1) What is the definition of limited disease? 2) Is thoracic irradiation needed and what are the benefits? 3) What is the optimal time and method of chest irradiation? 4) What are the optimal parameters of irradiation : dose, fractionation, target volume? 5) When radiochemotherapy is not possible at the outset, how should consider radiotherapy after induction chemotherapy ? 6) What is the optimal chemotherapy for limited stage SCLC? 7) Should preventive brain irradiation be given and if so, when and to which patients? 8) What is the complementary role of thoracic surgery in early SCLC?
authors.forename: S
authors.initials: S
authors.lastname: Holbrechts
authors.forename: M
authors.initials: M
authors.lastname: Roelandts
mesh_terms: D001932:Brain Neoplasms / Q000517:prevention & control; D059186:Chemoradiotherapy, Adjuvant / Q000379:methods; D017024:Chemotherapy, Adjuvant / Q000379:methods; D005060:Europe; D019317:Evidence-Based Medicine; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D018714:Radiotherapy, Adjuvant / Q000379:methods; D016032:Randomized Controlled Trials as Topic; D055752:Small Cell Lung Carcinoma / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D016896:Treatment Outcome